Literature DB >> 27138649

Partial Resuscitative Endovascular Balloon Occlusion of the Aorta in Swine Model of Hemorrhagic Shock.

Rachel M Russo1, Lucas P Neff2, Christopher M Lamb3, Jeremy W Cannon4, Joseph M Galante5, Nathan F Clement6, J Kevin Grayson7, Timothy K Williams8.   

Abstract

BACKGROUND: Complete resuscitative endovascular balloon occlusion of the aorta (C-REBOA) increases proximal mean arterial pressure (MAP) at the cost of distal organ ischemia, limiting the duration of intervention. We hypothesized that partial aortic occlusion (P-REBOA) would maintain a more physiologic proximal MAP and reduce distal tissue ischemia. We investigated the hemodynamic and physiologic effects of P-REBOA vs C-REBOA. STUDY
DESIGN: Fifteen swine were anesthetized, instrumented, splenectomized, and subjected to rapid 25% blood volume loss. They were randomized to C-REBOA, P-REBOA, or no intervention (controls). Partial REBOA was created by partially inflating an aortic balloon catheter to generate a 50% blood pressure gradient across the balloon. Hemodynamics were recorded and serum makers of ischemia and inflammation were measured. After 90 minutes of treatment, balloons were deflated to evaluate the immediate effects of reperfusion. End organs were histologically examined.
RESULTS: Complete REBOA produced supraphysiologic increases in proximal MAP after hemorrhage compared with more modest augmentation in the P-REBOA group (p < 0.01), with both groups significantly greater than controls (p < 0.01). Less rebound hypotension after balloon deflation was seen in the P-REBOA compared with C-REBOA groups. Complete REBOA resulted in higher serum lactate than both P-REBOA and controls (p < 0.01). Histology revealed early necrosis and disruption of duodenal mucosa in all C-REBOA animals, but none in P-REBOA animals.
CONCLUSIONS: In a porcine hemorrhagic shock model, P-REBOA resulted in more physiologically tolerable hemodynamic and ischemic changes compared with C-REBOA. Additional work is needed to determine whether the benefits associated with P-REBOA can both extend the duration of intervention and increase survival. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27138649     DOI: 10.1016/j.jamcollsurg.2016.04.037

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  25 in total

1.  The effect of resuscitative endovascular balloon occlusion of the aorta, partial aortic occlusion and aggressive blood transfusion on traumatic brain injury in a swine multiple injuries model.

Authors:  M Austin Johnson; Timothy K Williams; Sarah-Ashley E Ferencz; Anders J Davidson; Rachel M Russo; William T O'Brien; Joseph M Galante; J Kevin Grayson; Lucas P Neff
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

2.  Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Kiril Chtraklin; Panpan Chang; Nathan J Graham; Basil M Baccouche; Shalini Roy; Mohammed Harajli; Jing Zhou; Vahagn C Nikolian; Qiufang Deng; Yuzi Tian; Baoling Liu; Yongqing Li; Gregory L Hays; Julia L Hays; Hasan B Alam
Journal:  J Vis Exp       Date:  2018-08-24       Impact factor: 1.355

3.  Distal pressure monitoring and titration with percent balloon volume: feasible management of partial resuscitative endovascular balloon occlusion of the aorta (P-REBOA).

Authors:  Yosuke Matsumura; Akiko Higashi; Yoshimitsu Izawa; Shuji Hishikawa; Hiroshi Kondo; Viktor Reva; Shigeto Oda; Junichi Matsumoto
Journal:  Eur J Trauma Emerg Surg       Date:  2019-11-06       Impact factor: 3.693

Review 4.  [Resuscitative endovascular balloon occlusion of the aorta : Option for incompressible trunk bleeding?]

Authors:  J Knapp; M Bernhard; T Haltmeier; D Bieler; B Hossfeld; M Kulla
Journal:  Anaesthesist       Date:  2018-04       Impact factor: 1.041

5.  Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for Severe Torso Trauma in Japan: A Descriptive Study.

Authors:  Shokei Matsumoto; Kei Hayashida; Taku Akashi; Kyoungwon Jung; Kazuhiko Sekine; Tomohiro Funabiki; Takashi Moriya
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

6.  Automated variable aortic control versus complete aortic occlusion in a swine model of hemorrhage.

Authors:  Timothy K Williams; Lucas P Neff; Michael Austin Johnson; Rachel M Russo; Sarah-Ashley Ferencz; Anders J Davidson; Nathan F Clement; John Kevin Grayson; Todd E Rasmussen
Journal:  J Trauma Acute Care Surg       Date:  2017-04       Impact factor: 3.313

7.  A combat casualty relevant dismounted complex blast injury model in swine.

Authors:  Alexis L Cralley; Ernest E Moore; Daniel Kissau; Julia R Coleman; Navin Vigneshwar; Margot DeBot; Terry R Schaid; Hunter B Moore; Mitchell J Cohen; Kirk Hansen; Christopher C Silliman; Angela Sauaia; Charles J Fox
Journal:  J Trauma Acute Care Surg       Date:  2022-05-12       Impact factor: 3.697

8.  Traumatic brain injury may worsen clinical outcomes after prolonged partial resuscitative endovascular balloon occlusion of the aorta in severe hemorrhagic shock model.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Nathan J Graham; Vahagn C Nikolian; Kiril Chtraklin; Panpan Chang; Jing Zhou; Ben E Biesterveld; Jonathan Eliason; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2019-03       Impact factor: 3.313

9.  Endocrine Effects of Simulated Complete and Partial Aortic Occlusion in a Swine Model of Hemorrhagic Shock.

Authors:  Guillaume L Hoareau; Timothy K Williams; Anders J Davidson; Rachel M Russo; Sarah-Ashley E Ferencz; Lucas P Neff; J Kevin Grayson; Ian J Stewart; M Austin Johnson
Journal:  Mil Med       Date:  2019-05-01       Impact factor: 1.437

Review 10.  Resuscitative endovascular balloon occlusion of the aorta in combat casualties: The past, present, and future.

Authors:  Sarah C Stokes; Christina M Theodorou; Scott A Zakaluzny; Joseph J DuBose; Rachel M Russo
Journal:  J Trauma Acute Care Surg       Date:  2021-08-01       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.